Hongjun Fu Selected Research

Hongjun Fu Research Topics

Disease

13	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 09/2006
6	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 05/2007
3	Skin Diseases (Skin Disease) 06/2022 - 04/2014
2	Infections 06/2022 - 05/2016
2	Melanoma (Melanoma, Malignant) 04/2017 - 10/2016
2	Neoplasms (Cancer) 04/2017 - 10/2016
2	Stroke (Strokes) 09/2007 - 07/2007
1	Granuloma 06/2022
1	Frontotemporal Dementia With Motor Neuron Disease 01/2022
1	Amyloidosis 01/2022
1	Huntington Disease (Huntington's Disease) 01/2022
1	Parkinson Disease (Parkinson's Disease) 01/2022
1	Diabetic Retinopathy (Retinopathy, Diabetic) 05/2021
1	Wolfram Syndrome (Syndrome, Wolfram) 11/2020
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2020
1	Diabetes Insipidus 11/2020
1	Hearing Loss (Hearing Impairment) 11/2020
1	Atrophy 11/2020
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2018
1	Mycoses (Diseases, Fungus) 05/2016
1	Tauopathies 01/2016
1	Inflammation (Inflammations) 08/2015
1	Cognitive Dysfunction 07/2015
1	Allergic Contact Dermatitis 04/2015
1	Memory Disorders (Memory Loss) 01/2015
1	Body Weight (Weight, Body) 09/2013
1	Meningoencephalitis 04/2013
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 06/2010
1	Ischemia 09/2007
1	Mitochondrial Diseases (Mitochondrial Disease) 07/2007
1	Wounds and Injuries (Trauma) 04/2006

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2013
4	Amyloid (Amyloid Fibrils)IBA 01/2020 - 05/2012
3	Amyloid beta-PeptidesIBA 01/2022 - 09/2006
3	peoniflorinIBA 09/2016 - 04/2014
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 06/2010 - 05/2007
2	Pharmaceutical PreparationsIBA 06/2022 - 06/2010
2	Small Nuclear RNA (snRNA)IBA 01/2021 - 11/2020
2	Small Cytoplasmic RNAIBA 01/2021 - 11/2020
2	RNA (Ribonucleic Acid)IBA 01/2021 - 11/2020
2	PerforinIBA 04/2017 - 10/2016
2	Granzymes (Granzyme)IBA 04/2017 - 10/2016
2	bis(heptyl)cognitinIBA 07/2015 - 06/2010
2	N-Methylaspartate (NMDA)IBA 06/2010 - 09/2007
2	Glutamic Acid (Glutamate)FDA Link 06/2010 - 07/2007
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2007 - 04/2006
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 06/2022
1	AcidsIBA 06/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2022
1	diazonaphthalenedisulfonic acid (NDS)IBA 01/2022
1	methyl 4-azidophenylacetimidate (APAI)IBA 05/2021
1	Calcitriol Receptors (Calcitriol Receptor)IBA 05/2021
1	huperzine AIBA 01/2021
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2021
1	Tacrine (Cognex)FDA Link 01/2021
1	Insulin (Novolin)FDA Link 11/2020
1	IronIBA 11/2020
1	SulfurIBA 11/2020
1	Peptides (Polypeptides)IBA 01/2020
1	Serine (L-Serine)FDA Link 01/2018
1	Ala Transfer RNAIBA 01/2018
1	Alanine-tRNA LigaseIBA 01/2018
1	Conditioned Culture MediaIBA 04/2017
1	InterleukinsIBA 04/2017
1	undecylenic acidIBA 05/2016
1	Virulence Factors (Pathogenicity Factors)IBA 05/2016
1	tau Proteins (tau Protein)IBA 01/2016
1	Apolipoproteins E (ApoE)IBA 08/2015
1	F-Box ProteinsIBA 08/2015
1	HaptensIBA 04/2015
1	SeleniumIBA 01/2015
1	CMP- N- acetylneuraminate- poly- alpha- 2,8- sialosyl sialyltransferaseIBA 09/2013
1	SialyltransferasesIBA 09/2013
1	Messenger RNA (mRNA)IBA 09/2013
1	AN-1792IBA 04/2013
1	Complement System Proteins (Complement)IBA 05/2012
1	Memantine (Namenda)FDA Link 06/2010
1	bis(propyl)cognitinIBA 06/2010
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 02/2008
1	Therapeutic UsesIBA 09/2007
1	Protons (Proton)IBA 09/2007
1	1,7- N- heptylene- bis- 9,9'- amino- 1,2,3,4- tetrahydroacridineIBA 09/2007
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 07/2007
1	AcetylcholinesteraseIBA 09/2006
1	Arginine (L-Arginine)FDA Link 04/2006
1	Nitric Oxide Synthase (NO Synthase)IBA 04/2006

Therapy/Procedure

3	Therapeutics 01/2021 - 02/2008
2	Immunotherapy 10/2016 - 04/2013
1	Photochemotherapy (Photodynamic Therapy) 06/2022
1	Oral Administration 04/2015